Thousands of people are filing a class action lawsuit against the manufacturer of Valsartan for injuries and illnesses caused by the drug. The lawsuit claims that the drug is linked to cancer, and is responsible for the deaths of hundreds of people. The lawsuit is also seeking damages for the cost of treating patients who have been injured by the drug.

NDMA

NDMA Lawsuit against Valsartan claims that cancer was caused by contamination with the carcinogen NDMA in the popular drug. According to the lawsuits, many batches of Valsartan were contaminated.

Valsartan is a drug used to treat high blood pressure and heart failure. The drug is manufactured by several companies. It is used by millions of people every year. It is considered safe when compounded correctly.

The drugmaker Zhejiang Huahai Pharmaceuticals has been accused of manufacturing contaminated pharmaceuticals since 2012. The company is a Chinese firm that supplies several manufacturers.

The FDA issued a recall of Valsartan in July of 2018. The pharmaceuticals were contaminated with NDMA. The drug has been associated with liver, colorectal, and kidney cancer. Patients who took FDA-recalled lots of Valsartan reported cancer and liver damage.

Litigation process

Those who have suffered injuries due to tainted Valsartan should contact a lawyer to learn more about their legal options. A lawyer will advise you on the strength of your claim, as well as help you through the litigation process.

Valsartan is a blood pressure medication that is commonly used. Some people have taken it and later developed cancer. The drug is an angiotensin ii receptor blocker. However, it may be contaminated with carcinogens.

The FDA recently recalled Valsartan and related medicines due to higher scrutiny of foreign drug imports. A number of lawsuits have been filed against Valsartan manufacturers. A lawsuit filed by one consumer claims that the drug was tainted with NDMA, a probable human carcinogen.

Valsartan Lawsuit are brought by people who took the drug and later developed cancer. In addition, many patients claim that the drug’s manufacturers ignored required safety procedures.

Cost of cancer treatment

Whether or not you are considering Valsartan for your cancer treatment, it is important to understand how it may cost. Cancer treatment can be expensive, and insurance providers are often under strict rules when it comes to covering these types of services. If you have questions, find a trusted friend or family member to help you with this process.

The cost of cancer treatments has increased by 10% each year for the past five years, according to estimates. In the United States, cancer treatment costs are estimated at approximately $183 billion annually. These costs are paid by employers, health insurance providers, and patients. In 2018, cancer patients paid $5.6 billion out-of-pocket for their treatments. Insurers often impose strict criteria, such as prior authorizations and tiered out-of-pocket coverage.

Damages sought

Several individuals, families and patients have filed a lawsuit against the manufacturer of the drug Valsartan. The lawsuits allege that the drugs contained nitrosamine byproducts, known as NDMA. These products are linked to an increased risk of cancer.

The Valsartan lawsuits are filed in New Jersey federal court. The lawsuits are based on the idea that the manufacturer failed to warn the public about the risks associated with the medication. NDMA is a probable human carcinogen, and it has been found in laboratory animals to cause cancer.

The lawsuits also allege that the manufacturer was negligent in the manufacturing process. The company, Zhejiang Huahai Pharmaceutical, is located in China. It supplies several companies, including manufacturers, distributors and retailers.

Valsartan was recalled in July 2018 after testing showed that the drug contained NDMA. It is a drug used to treat high blood pressure and heart failure.

Class action lawsuit

Hundreds of people are claiming they were exposed to cancer-causing chemicals in a generic drug. The lawsuits allege that the pharmaceutical companies that manufactured the tainted medicine violated the law. The plaintiffs’ attorneys claim that the companies made misleading statements about their products.

Valsartan is a drug used for blood pressure. It was recently recalled due to the presence of an impurity. The drug was found to contain N-nitrosodimethylamine (NDMA), a substance that is known to cause cancer in animals.

The FDA announced an initial recall of several valsartan lots in 2018. The drug was found to contain NDMA in both the United States and Europe.

More than one hundred personal injury lawsuits have been filed against the valsartan manufacturers. In a few cases, the plaintiffs are claiming the drug caused them liver damage and cancer.